Skip to content

NICU-TECH RM9L-RS Probe ME Feasibility Study

NICU-TECH RM9L-RS Probe ME Feasibility Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01181596
Enrollment
31
Registered
2010-08-13
Start date
2010-06-30
Completion date
2011-11-30
Last updated
2019-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonates

Keywords

neonates and infants, from the 23-week gestational (0.5 kg), up to a 6 month old born at term (7 kg), for whom the PIV,, PAC, UAC, UVC or PICC catheter insertion is medically, indicated.

Brief summary

Use of a new ultrasound device designed for babies to look at the catheters in veins and arteries as well as the blood vessel itself. An observational study to assess the the clinicians perception of the ultrasound image quality as a tool to detect catheters in vessels.

Detailed description

The intent of the study is to confirm the maximum penetration of the NICU-Tech RM9L-RS probe. The investigators collected images on patients with PIV (Peripheral Intra Venous)/PAC (Peripheral Arterial Catheter) and central line catheters. The investigators collected images of deep vessel structures for offline processing to improve NICU-Tech algorithms for vessel segmentation.

Interventions

None listed

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
23 Weeks to 6 Months
Healthy volunteers
No

Inclusion criteria

* Neonates that are 23 gestational weeks at birth (and greater than 500 grams) to a 6 month old born infant at term (maximum weight 7 kg) who already have one or more lines placed (PIV/PAC/UVC/UACs/PICC) as part of their medical care. NO INFANT WILL HAVE A LINE PLACE FOR THE PURPOSE OF THIS STUDY

Exclusion criteria

* Neonates that are less than 23 gestational weeks at birth * Neonates that are 23 gestational weeks at birth but are less than 500 grams in weight * Patients weighing more than 7 kg.-Patients older than 6 months

Design outcomes

Primary

MeasureTime frameDescription
Participants That Fulfilled All Study Procedures.1 day (day of procedure)Acquisition of basic images and video were obtained from study participants who already have one or more catheters in place.
Vessel Penetration of NICU-Tech RM9L-RS Probe1 day (day of procedure)The algorithmic depth of vessel penetration will be collected.

Countries

United States

Participant flow

Recruitment details

This is an observational study where recruitment took place in the Neonatal Intensive Care Unit. Enrollment period of June 2010 - November 2011.

Pre-assignment details

If participants health worsens prior to assignment they were excluded from the study.

Participants by arm

ArmCount
Ultrasound Probing
Ultrasound probing to guide catheter placement
31
Total31

Baseline characteristics

CharacteristicUltrasound Probing
Age, Categorical
<=18 years
31 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous0.5 years
STANDARD_DEVIATION 0.02
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 31
other
Total, other adverse events
0 / 31
serious
Total, serious adverse events
0 / 31

Outcome results

Primary

Participants That Fulfilled All Study Procedures.

Acquisition of basic images and video were obtained from study participants who already have one or more catheters in place.

Time frame: 1 day (day of procedure)

Population: Study participants who have one or more catheters in place.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Arm 1: Observational UltrasoundParticipants That Fulfilled All Study Procedures.31 Participants
Primary

Vessel Penetration of NICU-Tech RM9L-RS Probe

The algorithmic depth of vessel penetration will be collected.

Time frame: 1 day (day of procedure)

Population: Images were not adequate to visualize catheter penetration, or to obtain measurements.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026